GPs good at ruling out depression in primary care, but false positives common
Major depression disorder (MDD) causes psychosocial morbidity and complicates clinical outcomes of co-morbid medical conditions. 1-5 Many depressed individuals rely on primary care, and evidence suggests more needs to be done to improve case-fi nding errors in primary care settings. [6] [7] [8] [9] [10] [11] [12] Efforts to improve depression screening have shown mixed results, highlighting the need for focused interventions aimed at improving physician management of depression. 13 Mitchell and colleagues' meta-analysis 14 of unassisted diagnoses of depression may be the only comprehensive meta-analysis on the subject published and presents a clinical practice review that is subject to controversial interpretation. We expect their fi ndings to stir debate regarding the quality of depression diagnosis in primary care. It is comforting that their evidence supports historical improvement in diagnostic practice quality, despite their highlighting diagnostic accuracy issues such as overdiagnosis. Overall this study contributes to the evidence base required to improve diagnosis of depression. This meta-analysis employed rigorous selection methods and included a pooled sample of 50 371 patients from 41 studies. MDD was diagnosed using standardised assessments. Typical meta-analytic techniques were used. Reported MDD prevalence was slightly higher than in most previous studies in similar settings. 15 Wide variations in GP case-note diagnostic sensitivity were reported (6.6% to 78.8%), with an overall sensitivity of 47.3%, similar to published reports for such settings. Higher ratings were reported for contemporaneous rating and cumulative recognition versus cross-sectional ratings (36.8% vs 29.9%). Findings of studies reporting full data for rule-in and rule-out diagnostic accuracy showed a sensitivity of 50.1% and specifi city of 82.4%, which suggest quality differences in the contrasting studies. The review concludes that although GPs generally rule out depression correctly, there are signifi cant numbers of false positives; misidentifi cations outnumber missed cases with concerning frequency.
The study methods were suitable for the research inquiry. Because of the heterogeneity of studies and outcomes, comparison of fi xed effect with conducted random effect analysis might have provided further clarity. Funnel plot asymmetry tests using methods described by Egger and colleagues, 16 for example, might have enabled a wider appreciation of the uniformity of the reported observations. Issues regarding wide sample size variations among selected publications and the potential for publication bias warrant this approach (Simon and colleagues' study accounts for about 50% of the entire study sample
17
). In addition, MDD classifi cation using research-based interview or expert diagnosis criteria (11 studies) raises concerns about standardisation of diagnostic criteria. Finally, differentials in case-note-based MDD rating sensitivity versus contemporaneous rating may refl ect underlying self-rating bias. Overall the study draws appropriate conclusions.
This meta-analysis highlights the need for improved depression diagnosis in primary care. Some studies fi nd that depression treatment is provided to most individuals with MDD, but some studies suggest otherwise. [18] [19] [20] Where patients' clinical needs become better appreciated with more encounters, improved diagnosis follows. The study's important fi nding that "unassisted" physicians may do just as well as those using validated instruments in ruling out depression could imply that physicians differ in their abilities to assess mood states, perhaps as a result of differences in training or emotional sensitivity. [21] [22] [23] [24] This questions the need for universal structured depression screening.
So why can GPs rule out MDD in most non-depressed people, while struggling with misidentifi cations and correct identifi cations of true cases? Although the authors suggest low depression prevalence, similar prevalence for non-psychiatric medical conditions does not appear to affect diagnostic quality. Perhaps this is better explained by GPs' struggles with differentiating MDD from subsyndromal states or other mood disorders; that is, they know generally that someone is depressed but not what type of depression. The study's fi nding of MDD overdiagnosis has important clinical implications. Does this lead to antidepressant misuse, with associated medical risks, or will it inadvertently pull GPs away from diagnosing the entire spectrum of depressive disorders? We suspect that MDD overinclusion speaks more to the need for improved quality of diagnosis than to a need to decrease diagnoses.
Studies that explore the cost and clinical implications of MDD overdiagnosis are required. The authors' suggestion for more allocated encounter time to reduce diagnostic error is unlikely to be taken up without continued advocacy and supportive evidence. Quality meta-analyses such as this review are important, but they provide little explanatory information for the reasons behind misdiagnosis; we also need mixed-method studies, including comprehensive qualitative studies, such as direct observation studies of practising clinicians.
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